Use of pharmacotherapy for alcohol use disorder in Manitoba, Canada: A whole-population cohort study.

ABSTRACT:

Objective

Update the evidence on use of pharmacotherapy for alcohol use disorder in a Canadian population.

Methods

Using whole-population administrative data from Manitoba, Canada, we identified all residents age 12+ who were first diagnosed with alcohol use disorder between April 1, 1996 and March 31, 2015, and compared characteristics of those who filled a prescription for naltrexone, acamprosate or disulfiram at least once during that period to those who did not fill a prescription for an alcohol use disorder medication.

Results

Only 1.3% of individuals with alcohol use disorder received pharmacotherapy (62.3% of prescriptions were for naltrexone, 39.4% for acamprosate, 7.5% for disulfiram). Most prescriptions came from family physicians in urban alcohol use disord

SUBMITTER: Konrad G 

PROVIDER: S-EPMC8415582 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature